FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Interferon beta-1b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon gamma (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing interferon gamma-1b (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only interferon gamma-1b (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b 200 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon gamma-1b-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Azacitidine-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only azacitidine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only azacitidine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing azacitidine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely azacitidine 100 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely azacitidine 200 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely azacitidine 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pralsetinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 1 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing arsenic trioxide in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab 5 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idelalisib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idelalisib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ceritinib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing ingenol mebutate (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate only product in cutaneous dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only ingenol mebutate (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ingenol mebutate-containing product in cutaneous dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cobimetinib (as cobimetinib fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely everolimus 2.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only naxitamab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Naxitamab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only naxitamab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing anthracycline and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing Vinca alkaloid and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing nitrosurea and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing purine analog and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing axicabtagene ciloleucel (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Axicabtagene ciloleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Podophyllotoxin and/or podophyllotoxin derivative antineoplastic agent Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing tisagenlecleucel (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing tisagenlecleucel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tisagenlecleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cetuximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cetuximab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing duvelisib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Duvelisib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Relugolix-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only relugolix (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing relugolix in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only relugolix in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely relugolix 120 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only margetuximab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Margetuximab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib 300 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 2 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely arsenic trioxide 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rituximab 10 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cladribine 1 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 500 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Bosutinib 400 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 200 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 500 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely nilotinib (as nilotinib hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cyclophosphamide 1 g powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing tepotinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tepotinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing tepotinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only umbralisib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib (as umbralisib tosylate) 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 14 of 17 Next End

This concept is not in any reference sets

Back to Start